Annex to newsletter regarding the BPTO Resolution 80/2013.
The full list of products considered strategic by Ministry
of Health and neglected diseases is discriminated in
ordinances No. 978/2008 and No. 1284/2010 of Ministry of Healthy and Annex 1 of Resolution 80/2013. I. Pharmaceutical segment 1. Antiviral (including antiretroviral): Atazanavir Darunavir Efavirenz Enfuvirtide Entecavir Lopinavir Raltegravir Ritonavir Tenofovir 2. Related to neglected diseases Liposomal Amphotericin B Meglumine antimoniate Artesunate Benznidazole Clofazimine Chloroquine Dapsone Amphotericin B deoxycholate Ethambutol Ethionamide Isoniazid Mefloquine Nifurtimox Pyrazinamide Praziquantel Primaquine Rifabutin Rifampicin 3. Related to not transmissible chronic disease (Alzheimer) Donepezil
Rivastigmine (Anti-Asthmatics) Budesonide Formoterol (Antiparkinsonian) Cabergoline Entacapone Tolcapone Pramipexole Selegiline (antipsychotics and anticonvulsants) Clozapine Olanzapine Primidone Quetiapine Topiramate Ziprasidone (antirheumatic and anti-inflammatory) Leflunomide
Mesalazine (Immunosuppressive) Everolimus Mycophenolate mofetil Mycophenolate sodium Tacrolimus Sirolimus (osteoporosis) Calcitonin Calcitriol Raloxifene (pulmonary arterial hypertension) Iloprost Sildenafil (other indications) Bromocriptine Sevelamer hydrochloride Statins Glatiramer Riluzole Somatostatin 4. Products obtained by biological routes: (Monoclonal Antibodies) Adalimumab Dasatinib Imatinib Infliximab Nilotinib Rituximab Trastuzumab Others (enzimes) Alpha dornase Glucocerebrosidase Others (hormones) Insulin-like growth factor (IGF-1) Filgrastim Human chorionic gonadotrophin (HCG) and Pregnant mare's serum gonadotropin (PMSG) Goserelin Glucagon Follicle stimulating hormone Insulin Leuprorelin Somatotropin Others (proteins) Etanercept Procoagulant factors Interferons Octreotide Botulinum toxin Others 5. Vaccines and blood products 6. Medicines and supplies for the therapy of disorders resulting from nuclear accidents II. Segment of medical devices and general devices of support health
Category I - Medical Devices 1. Active medical product for diagnosis A) Diagnostic imaging equipment Flexible and Rigid Endoscopy Equipment Ultrasound diagnostic equipment B) Equipment for in vitro and in vivo diagnostics Equipment that directly generates results for in vitro diagnostic 2. Active medical product for therapy A) Dialysis equipment Hemodialysis equipment and accessories, B) Equipment for general therapy Individual hearing aids (hearing aid) 3. Implantable medical Product A) implantable device Cochlear implant with electric generator Pacemaker, defibrillator and Cardioconversor Implantable device/ Material / article Intrauterine device (IUD) Vena cava filter Cochlear implants with mechanical components only Hip and knee prosthesis with porous coating technology applied to its surface Coronary stent 4. Active medical product for physician-hospital support A) refrigerated centrifuge for blood bag B) freezer /ultralow temperature conservative for samples, blood, vaccines C) simulators for diagnostic imaging equipment 5. Non active medical product for physician-hospital support A) bag for collection and storage of human blood B) dialyzers, needles fistulas and thread for hemodialysis C) medical devices used for contraception or to prevent the transmission of sexually transmitted diseases D) Surgical and procedure synthetic gloves 6. Diagnostic products for use in vivo A) diagnostic kits for detection of diseases and supplies for their production AIDS Botulism Dengue Diphtheria Chagas disease West Nile virus Brazilian spotted fever Leprosy Hantavirus Hepatitis Influenza Cutaneous leishmaniasis Visceral leishmaniasis Malaria Tuberculosis Category II – general devices for health support Equipment for testing and evaluation of the safety and
performance of electrical apparatus under the health surveillance regime, according to specifications of the standard series ABNT NBR IEC 60601 Category III – neglected diseases Chagas disease Dengue Schistosomiasis Leprosy Leishmaniosis Malaria Tuberculosis Buruli ulcer Neurocysticercosis Echinococcosis Bouba Fascioliasis Paragonimiasis Filariasis Rabies Helminthiasis and Manifestations resulting from intoxication or poisoning due to poisonous or venomous animals.
Shared aspirations: The imperative of accountability in South Africa’s electoral system By Dr Wilmot James and Mr Adrian Hadland, Social Cohesion and Integration Research Programme, Human Sciences Research 1 Constitutional Considerations “We can believe what we choose. We are answerable for what we choose to believe” - In a country in which the constitution is supreme
Veröffentlichungen Dr. med. Thomas Sternfeld Wie viel Lebensqualität geht auf dem Weg zum Onkologen verloren? U. Vehling-Kaiser, F. Kaiser, D. Illig, T. Sternfeld , Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie 2013, Wien, 18. - 22. Oktober 2013 Primäres ZNS-Marginalzonenlymphom bei einem erwachsenen Patienten
Annex to newsletter regarding the BPTO Resolution 
Mesalazine (Immunosuppressive) Everolimus Mycophenolate mofetil Mycophenolate sodium Tacrolimus Sirolimus (osteoporosis) Calcitonin Calcitriol Raloxifene (pulmonary arterial hypertension) Iloprost Sildenafil (other indications) Bromocriptine Sevelamer hydrochloride Statins Glatiramer Riluzole Somatostatin 4. Products obtained by biological routes: (Monoclonal Antibodies) Adalimumab Dasatinib Imatinib Infliximab Nilotinib Rituximab Trastuzumab Others (enzimes) Alpha dornase Glucocerebrosidase Others (hormones) Insulin-like growth factor (IGF-1) Filgrastim Human chorionic gonadotrophin (HCG) and Pregnant mare's serum gonadotropin (PMSG) Goserelin Glucagon Follicle stimulating hormone Insulin Leuprorelin Somatotropin Others (proteins) Etanercept Procoagulant factors Interferons Octreotide Botulinum toxin Others 5. Vaccines and blood products 6. Medicines and supplies for the therapy of disorders resulting from nuclear accidents II. Segment of medical devices and general devices of support health
performance of electrical apparatus under the health surveillance regime, according to specifications of the standard series ABNT NBR IEC 60601 Category III – neglected diseases Chagas disease Dengue Schistosomiasis Leprosy Leishmaniosis Malaria Tuberculosis Buruli ulcer Neurocysticercosis Echinococcosis Bouba Fascioliasis Paragonimiasis Filariasis Rabies Helminthiasis and Manifestations resulting from intoxication or poisoning due to poisonous or venomous animals.